Poly(I:C) is a promising adjuvant for
cancer treatment
vaccines to enhance the host anti-tumour immune response. However, the roles of
poly(I:C) in the
cervical cancer microenvironment and local immune reactions are not well understood. In this study, we investigated the roles of
poly(I:C) in the
cervical cancer. We analysed the
cytokine transcription and secretion of
cervical cancer cell lines and THP-1-derived macrophages after
poly(I:C) treatment, respectively. These results revealed that
IL-6 was significantly up-regulated, and this up-regulation was partly dose dependent.
poly(I:C)-stimulated supernatant of
cervical cancer cells promoted M1-type
cytokine IL-1β and
IL-6 expression of THP-1-derived macrophages, but inhibited the expression of M2-type
cytokine,
IL-10 and CCL22. The recruitment of THP-1-derived macrophages by
poly(I:C)-stimulated
cervical cancer cell supernatant was also enhanced. Inhibition of
IL-6 expression in
cervical cancer cells by
siRNA transfection almost completely reversed the effects of
poly(I:C) treatment. Finally, we found that phosphorylation of the NF-κB signalling pathway in
cervical cancer cells occurred quickly after
poly(I:C) treatment. Moreover, the NF-κB signalling pathway inhibitor
PDTC significantly inhibited
poly(I:C)-induced
IL-6 expression. Taken together, these results suggest that
poly(I:C) might regulate the effects of
cervical cancer cells on tumour-infiltrated macrophages, and subsequently promote a pro-inflammatory tumour microenvironment.